Skip to main content

ADVERTISEMENT

abdominal aortic aneurysm

Clinical Review
12/04/2016

Eric Ducasse, MD; Caroline Caradu, MD; Xavier Berard, MD; Gerard Sassoust, MD; Dominique Midy, MD

Department of Vascular Surgery, University of Bordeaux, University Hospital of Bordeaux, Bordeaux, France

Eric Ducasse, MD; Caroline Caradu, MD...
The authors review the literature reporting comparative results between FEVAR and CHEVAR of complex aortic aneurysms.
The authors review the literature reporting comparative results between FEVAR and CHEVAR of complex aortic aneurysms.
The authors review the...
12/04/2016
Vascular Disease Management
Editor's Corner
12/04/2016
Dr. Walker discusses an article from the December issue of Vascular Disease Management, in which Mengal et al present a case for which they utilized an endovascular approach to treat a symptomatic left subclavian artery aneurysm in a...
Dr. Walker discusses an article from the December issue of Vascular Disease Management, in which Mengal et al present a case for which they utilized an endovascular approach to treat a symptomatic left subclavian artery aneurysm in a...
Dr. Walker discusses an article...
12/04/2016
Vascular Disease Management
Clinical Review
08/30/2016

Kira N. Long, MD; Ross Milner, MD

University of Chicago Medicine & Biological Sciences, Chicago, Illinois

Kira N. Long, MD; Ross Milner, MD Un...
The chimney/snorkel technique is a practical alternative in emergent settings or as a salvage procedure when the renal arteries or superior mesenteric artery are covered. Although the technique is an off-label use of existing technology, it...
The chimney/snorkel technique is a practical alternative in emergent settings or as a salvage procedure when the renal arteries or superior mesenteric artery are covered. Although the technique is an off-label use of existing technology, it...
The chimney/snorkel technique is...
08/30/2016
Vascular Disease Management
03/01/2016
Vascular Disease Management spoke with William D. Jordan, MD, about the ANCHOR prospective, multicenter registry, which seeks to evaluate Heli-FX EndoAnchors (Aptus Endosystems) for the prevention of endoleak and stent-graft migration in...
Vascular Disease Management spoke with William D. Jordan, MD, about the ANCHOR prospective, multicenter registry, which seeks to evaluate Heli-FX EndoAnchors (Aptus Endosystems) for the prevention of endoleak and stent-graft migration in...
Vascular Disease Management...
03/01/2016
Vascular Disease Management
Interview
03/01/2016
Vascular Disease Management spoke with William D. Jordan, MD, about the ANCHOR prospective, multicenter registry, which seeks to evaluate Heli-FX EndoAnchors (Aptus Endosystems) for the prevention of endoleak and stent-graft migration in...
Vascular Disease Management spoke with William D. Jordan, MD, about the ANCHOR prospective, multicenter registry, which seeks to evaluate Heli-FX EndoAnchors (Aptus Endosystems) for the prevention of endoleak and stent-graft migration in...
Vascular Disease Management...
03/01/2016
Vascular Disease Management
Case Report
03/01/2016

Carlo J. Puzzo, DO1  Stephen R. Gallo, MD1; Mohammed Abdallah, DO2

 

1Nova Southeastern University, Fort Lauderdale, Florida;  2Broward Health, Fort Lauderdale, Florida

Carlo J. Puzzo, DO1  Stephen R. Gallo...
The authors describe an operative technique, which included both an endovascular approach as well as an open approach, and discuss the results of current research.
The authors describe an operative technique, which included both an endovascular approach as well as an open approach, and discuss the results of current research.
The authors describe an...
03/01/2016
Vascular Disease Management
01/26/2016
The authors aim to determine whether, in a group of patients with an established familial pattern of aortic disease, there is a risk of development of new aneurysm in the follow-up period, and whether this risk differs from that of patients...
The authors aim to determine whether, in a group of patients with an established familial pattern of aortic disease, there is a risk of development of new aneurysm in the follow-up period, and whether this risk differs from that of patients...
The authors aim to determine...
01/26/2016
Vascular Disease Management
01/26/2016

Roy Miler, MD1; Christopher R. Marcellino, MD2; Rocio T. Moran, MD3; Matthew J. Eagleton, MD1; Chase R. Brown, MD1; James Bena, MD1; Tara M. Mastracci, MD4

 

1Cleveland Clinic, Cleveland, Ohio; 2Case Western Reserve University, Cleveland, Ohio; 3MetroHealth Medical Center, Cleveland, Ohio; 4Royal Free London NHS Foundation Trust, London, United Kingdom.

Roy Miler, MD1; Christopher R. Marcel...
The authors aim to determine whether, in a group of patients with an established familial pattern of aortic disease, there is a risk of development of new aneurysm in the follow-up period, and whether this risk differs from that of patients...
The authors aim to determine whether, in a group of patients with an established familial pattern of aortic disease, there is a risk of development of new aneurysm in the follow-up period, and whether this risk differs from that of patients...
The authors aim to determine...
01/26/2016
Vascular Disease Management
Clinical Review
07/28/2015

George Galyfos, MD, PhD; Grigorios Voulalas, MD, PhD; Ioannis Stamatatos, MD, MSc; Stavros Kerasidis, MD, MSc; Ioannis Stefanidis, MD, MSc; Sotirios Giannakakis, MD, PhD; Georgios Kastrisios, MD; Georgios Geropapas, MD, MSc; Gerasimos Papacharalampous, MD; Chrisostomos Maltezos, MD, PhD

Department of Vascular Surgery, KAT General Hospital, Athens, Greece

George Galyfos, MD, PhD; Grigorios Vo...
This review aims to collect and present all available research data on the development and progress of small abdominal aortic aneurysms.
This review aims to collect and present all available research data on the development and progress of small abdominal aortic aneurysms.
This review aims to collect and...
07/28/2015
Vascular Disease Management
04/27/2015
At the 2014 VEITHsymposium, Vascular Disease Management spoke with Mark F. Fillinger, MD, about 2-year results of the Aorfix PYTHAGORAS trial, for which he served as principal investigator. 
At the 2014 VEITHsymposium, Vascular Disease Management spoke with Mark F. Fillinger, MD, about 2-year results of the Aorfix PYTHAGORAS trial, for which he served as principal investigator. 
At the 2014 VEITHsymposium,...
04/27/2015
Vascular Disease Management